Basic Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3559-3584
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Figure 8
Figure 8 The oncogenic mechanism of CASC19 to gastric cancer in vivo. A: The efficiency of lentivirus silencing CASC19 was verified by reverse transcription polymerase chain reaction (RT-PCR); B: The tumor growth rate of the CASC19 silencing lentivirus infection group was slower, and the tumor weight was significantly smaller than that of the negative control group; C: The hematoxylin and eosin staining of the tumor; D: Tumors were stained with TUNEL; E: The tumor was subjected to immunohistochemical staining; F: RT-PCR was performed on the tumor to examine the expression levels of CASC19, miR-491-5p, and HMGA2. bP < 0.05 was compared with the control group and P < 0.05 was considered statistically significant.